Sulfonylurea vs pioglitazone: effects on endothelial function in type 2 diabetic patients

被引：0
|
作者：
Naka, K. [1 ]
Papathanassiou, K. [1 ]
Kazakos, N. [1 ]
Bechlioulis, A. [1 ]
Pappas, K. [1 ]
Makriyiannis, D. [2 ]
Liveris, K. [2 ]
Tsatsoulis, A. [2 ]
Michalis, L. K. [2 ]
机构：
[1] Univ Ioannina, Sch Med, Dept Cardiol, Michaelid Cardiac Ctr, GR-45110 Ioannina, Greece
[2] G Hatzikosta Gen Hosp, Dept Endocrinol, Ioannina, Greece
来源：
EUROPEAN HEART JOURNAL | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：466 / 466
页数：1
相关论文
共 50 条
  • [41] The effects of carvedilol vs. metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus
    Kelly, Aaron S.
    Thelen, Andrea M.
    Kaiser, Daniel R.
    Bank, Alan J.
    DIABETES, 2007, 56 : A175 - A175
  • [42] Effect of pioglitazone on endothelial function, inflammation and plasma homocysteine in type 2 diabetes
    Kunhiraman, BP
    Asnani, S
    Lumpkin, D
    Japa, S
    Akers, D
    Fonseca, V
    DIABETES, 2005, 54 : A111 - A111
  • [43] Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients
    Nerla, Roberto
    Di Franco, Antonino
    Milo, Maria
    Pitocco, Dario
    Zaccardi, Francesco
    Tarzia, Pierpaolo
    Sarullo, Filippo Maria
    Villano, Angelo
    Russo, Giulio
    Stazi, Alessandra
    Ghirlanda, Giovanni
    Lanza, Gaetano Antonio
    Crea, Filippo
    HEART, 2012, 98 (24) : 1812 - 1816
  • [44] Effects of pioglitazone in combination with metformin or a sulfonylurea compared to a fixed-dose combination of metformin and glibenclamide in patients with type 2 diabetes
    Comaschi, M.
    Demlcheli, A.
    Di Pietro, C.
    Bellatreccia, A.
    Mariz, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2007, 9 (04) : 387 - 398
  • [45] Effects of 1 year treatment with pioglitazione vs sulfonylurea on lipid metabolism in type 2 diabetes patients
    Russo, M.
    Carli, F.
    Vitale, M.
    Masulli, M.
    Bozzetto, L.
    Della Pepa, G.
    Pezzica, S.
    Vaccaro, O.
    Rivellese, A.
    Gastaldelli, A.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S298 - S298
  • [46] Impact of pioglitazone on coronary endothelial function in non-diabetic patients with coronary artery disease
    Woehrle, Jochen
    Marx, Nikolaus
    Koenig, Wolfgang
    Hombach, Vinzenz
    Kestler, Hans A.
    Hoeher, Martin
    Nusser, Thorsten
    CLINICAL RESEARCH IN CARDIOLOGY, 2008, 97 (10) : 726 - 733
  • [47] Impact of pioglitazone on coronary endothelial function in non-diabetic patients with coronary artery disease
    Jochen Wöhrle
    Nikolaus Marx
    Wolfgang Koenig
    Vinzenz Hombach
    Hans A. Kestler
    Martin Höher
    Thorsten Nusser
    Clinical Research in Cardiology, 2008, 97 : 726 - 733
  • [48] Two-year effects of pioglitazone addition to sulfonylurea or metformin therapy on fasting serum insulin in patients with type 2 diabetes
    Urquhart, R
    Mariz, S
    Edwards, G
    Moules, I
    Tan, MH
    DIABETES, 2004, 53 : A149 - A149
  • [49] Effect of Pioglitazone on Glucose and Glycation Level in Type 2 Diabetic Patients
    Alim, Muhammad
    Nawaz, Rakhshanda
    Asi, Muhammad Rafique
    Anwar, Farooq
    Iqbal, Tahira
    INTERNATIONAL JOURNAL OF AGRICULTURE AND BIOLOGY, 2010, 12 (01) : 133 - 136
  • [50] Effect of pioglitazone on decreasing of proteinuria in type 2 diabetic patients with nephropathy
    Pourshabanan, Pejman
    Momeni, Ali
    Mahmoudnia, Leila
    Kheiri, Soleiman
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 132 - 136
12345